4//SEC Filing
Chapman Gina 4
Accession 0001610717-24-000492
CIK 0001966494other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 5:24 PM ET
Size
14.2 KB
Accession
0001610717-24-000492
Insider Transaction Report
Form 4
Chapman Gina
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-09-19−2,975→ 549,515 totalExercise: $5.03Exp: 2033-04-20→ Common Stock (2,975 underlying) - Sale
Common Stock
2024-09-19$25.03/sh−2,975$74,457→ 103,905 total - Exercise/Conversion
Common Stock
2024-09-18$5.03/sh+7,166$36,045→ 111,071 total - Exercise/Conversion
Common Stock
2024-09-19$5.03/sh+2,975$14,964→ 106,880 total - Sale
Common Stock
2024-09-18$25.09/sh−7,166$179,775→ 103,905 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-18−7,166→ 552,490 totalExercise: $5.03Exp: 2033-04-20→ Common Stock (7,166 underlying)
Footnotes (4)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 25, 2024.
- [F2]This transaction was executed in multiple trades in prices ranging from $25.00 to $25.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]This transaction was executed in multiple trades in prices ranging from $25.00 to $25.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]25% of the shares subject to the option vest on the first anniversary measured from February 9, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
CARGO Therapeutics, Inc.
CIK 0001966494
Entity typeother
Related Parties
1- filerCIK 0001989220
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 5:24 PM ET
- Size
- 14.2 KB